Agenda - Workshop on the use of Bayesian statistics in clinical development
Submitted by Anonymous (not verified) on 2 June 2025 - 16:16
Agenda - Workshop on the use of Bayesian statistics in clinical development
CAT quarterly highlights and approved ATMPs - May 2025
Submitted by Anonymous (not verified) on 2 June 2025 - 16:10
CAT quarterly highlights and approved ATMPs - May 2025
Organisation chart: Advisory functions
Submitted by Anonymous (not verified) on 2 June 2025 - 16:00
Organisation chart: Advisory functions
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, European Medicines Agency, Amsterdam, the Netherlands, from 10 April 2025 to 11 April 2025
Submitted by Anonymous (not verified) on 2 June 2025 - 16:00
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, European Medicines Agency, Amsterdam, the Netherlands, from 10 April 2025 to 11 April 2025
Meeting summary - Medicine shortages (SPOC) working party 10-11 April 2025
Submitted by Anonymous (not verified) on 2 June 2025 - 15:59
Meeting summary - Medicine shortages (SPOC) working party 10-11 April 2025
Human medicines European public assessment report (EPAR): Camzyos, mavacamten, Date of authorisation: 26/06/2023, Revision: 5, Status: Authorised
Submitted by Anonymous (not verified) on 2 June 2025 - 15:54
Human medicines European public assessment report (EPAR): Camzyos, mavacamten, Date of authorisation: 26/06/2023, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 67, Status: Authorised
Submitted by Anonymous (not verified) on 2 June 2025 - 15:50
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 67, Status: Authorised
Applicant / marketing authorisation holder change of contact person for product invented name / product number template
Submitted by Anonymous (not verified) on 2 June 2025 - 15:00
Applicant / marketing authorisation holder change of contact person for product invented name / product number template
Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)
Submitted by Anonymous (not verified) on 2 June 2025 - 14:52
Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)
Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation: 22/11/2018, Revision: 21, Status: Authorised
Submitted by Anonymous (not verified) on 2 June 2025 - 14:52
Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation: 22/11/2018, Revision: 21, Status: Authorised